These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 12909325

  • 1. Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction.
    Yoshida H, Takahashi M, Koshimizu M, Tanonaka K, Oikawa R, Toyo-oka T, Takeo S.
    Cardiovasc Res; 2003 Aug 01; 59(2):419-27. PubMed ID: 12909325
    [Abstract] [Full Text] [Related]

  • 2. Effects of ACE inhibitor and AT1 blocker on dystrophin-related proteins and calpain in failing heart.
    Takahashi M, Tanonaka K, Yoshida H, Oikawa R, Koshimizu M, Daicho T, Toyo-Oka T, Takeo S.
    Cardiovasc Res; 2005 Feb 01; 65(2):356-65. PubMed ID: 15639474
    [Abstract] [Full Text] [Related]

  • 3. Possible involvement of calpain activation in pathogenesis of chronic heart failure after acute myocardial infarction.
    Takahashi M, Tanonaka K, Yoshida H, Koshimizu M, Daicho T, Oikawa R, Takeo S.
    J Cardiovasc Pharmacol; 2006 Mar 01; 47(3):413-21. PubMed ID: 16633084
    [Abstract] [Full Text] [Related]

  • 4. Induction of heat shock protein 72 in the failing heart is attenuated after an exposure to heat shock.
    Tanonaka K, Toga W, Takahashi M, Yoshida H, Oikawa R, Takeo S.
    Mol Cell Biochem; 2004 Apr 01; 259(1-2):211-5. PubMed ID: 15124926
    [Abstract] [Full Text] [Related]

  • 5. Effects of angiotensin I-converting enzyme inhibitor and angiotensin II type 1 receptor blocker on the right ventricular sarcoglycans and dystrophin after left coronary artery ligation.
    Takahashi M, Tanonaka K, Yoshida H, Koshimizu M, Oikawa R, Daicho T, Takeo S.
    Eur J Pharmacol; 2005 Oct 17; 522(1-3):84-93. PubMed ID: 16185685
    [Abstract] [Full Text] [Related]

  • 6. Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters.
    Ikeda Y, Martone M, Gu Y, Hoshijima M, Thor A, Oh SS, Peterson KL, Ross J.
    Am J Physiol Heart Circ Physiol; 2000 Apr 17; 278(4):H1362-70. PubMed ID: 10749734
    [Abstract] [Full Text] [Related]

  • 7. Changes in Hsp60 level of the failing heart following acute myocardial infarction and the effect of long-term treatment with trandolapril.
    Toga W, Tanonaka K, Takeo S.
    Biol Pharm Bull; 2007 Jan 17; 30(1):105-10. PubMed ID: 17202668
    [Abstract] [Full Text] [Related]

  • 8. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction.
    Yamaguchi F, Sanbe A, Takeo S.
    Br J Pharmacol; 1998 Jan 17; 123(2):326-34. PubMed ID: 9489622
    [Abstract] [Full Text] [Related]

  • 9. Changes in small heat shock proteins HSPB1, HSPB5 and HSPB8 in mitochondria of the failing heart following myocardial infarction in rats.
    Marunouchi T, Abe Y, Murata M, Inomata S, Sanbe A, Takagi N, Tanonaka K.
    Biol Pharm Bull; 2013 Jan 17; 36(4):529-39. PubMed ID: 23546289
    [Abstract] [Full Text] [Related]

  • 10. Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy.
    Campos EC, O'Connell JL, Malvestio LM, Romano MM, Ramos SG, Celes MR, Prado CM, Simões MV, Rossi MA.
    Eur J Pharmacol; 2011 Nov 30; 670(2-3):541-53. PubMed ID: 21946105
    [Abstract] [Full Text] [Related]

  • 11. Utrophin and dystrophin-associated glycoproteins in normal and dystrophin deficient cardiac muscle.
    Rivier F, Robert A, Royuela M, Hugon G, Bonet-Kerrache A, Mornet D.
    J Muscle Res Cell Motil; 1999 Apr 30; 20(3):305-14. PubMed ID: 10471993
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of western immunoblot for evaluation of myocardial dystrophin, alpha-sarcoglycan, and beta-dystroglycan in dogs with idiopathic dilated cardiomyopathy.
    Spier AW, Meurs KM, Coovert DD, Lehmkuhl LB, O'Grady MR, Freeman LM, Burghes AH, Towbin JA.
    Am J Vet Res; 2001 Jan 30; 62(1):67-71. PubMed ID: 11197563
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel scheme of dystrophin disruption for the progression of advanced heart failure.
    Kawada T, Masui F, Tezuka A, Ebisawa T, Kumagai H, Nakazawa M, Toyo-Oka T.
    Biochim Biophys Acta; 2005 Aug 01; 1751(1):73-81. PubMed ID: 16054019
    [Abstract] [Full Text] [Related]

  • 18. Further evidence for the organisation of the four sarcoglycans proteins within the dystrophin-glycoprotein complex.
    Vainzof M, Moreira ES, Ferraz G, Passos-Bueno MR, Marie SK, Zatz M.
    Eur J Hum Genet; 1999 Aug 01; 7(2):251-4. PubMed ID: 10196712
    [Abstract] [Full Text] [Related]

  • 19. [A new paradigm for the progression of advanced heart failure].
    Kawada T, Nakazawa M, Toyo-oka T.
    Nihon Yakurigaku Zasshi; 2004 Feb 01; 123(2):55-62. PubMed ID: 14745124
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.